Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TTR | P02766 | 4/20 | 1.00 |
| ▸ | DPP4 | P27487 | 1/20 | 1.00 |
| ▸ | APP | P05067 | 11/20 | 0.78 |
| ▸ | MAOB | P27338 | 1/20 | 0.74 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.73 |
| ▸ | CA12 | O43570 | 1/20 | 0.69 |
| ▸ | CA1 | P00915 | 1/20 | 0.69 |
| ▸ | CA2 | P00918 | 1/20 | 0.69 |
| ▸ | CA7 | P43166 | 1/20 | 0.69 |
| ▸ | CA9 | Q16790 | 1/20 | 0.69 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.69 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.65 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.65 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.65 |
| ▸ | IAPP | P10997 | 2/20 | 0.64 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ethyl Caffeate SCHEMBL31059266 | 1.00 | TTR (1.00) | TTRDPP4APPMAOBCYP3A4 | |
| Ethyl Caffeate SCHEMBL30602576 | 1.00 | TTR (1.00) | TTRDPP4APPMAOBCYP3A4 | |
| Ethyl Caffeate SCHEMBL22196845 | 1.00 | TTR (1.00) | TTRDPP4APPMAOBCYP3A4 | |
| Ethyl Caffeate SCHEMBL30286241 | 1.00 | TTR (1.00) | TTRDPP4APPMAOBCYP3A4 | |
| Ethyl Caffeate SCHEMBL782032 | 1.00 | TTR (1.00) | TTRDPP4APPMAOBCYP3A4 | |
| Ethyl Caffeate SCHEMBL28088236 | 0.97 | TTR (0.94) | TTRDPP4APPMAOBCYP3A4 | |
| SCHEMBL4262080 | 0.97 | TTR (0.94) | TTRDPP4APPMAOBCYP3A4 | |
| SCHEMBL4262076 | 0.97 | TTR (0.94) | TTRDPP4APPMAOBCYP3A4 | |
| Ethyl Caffeate SCHEMBL28516367 | 0.95 | TTR (0.91) | TTRDPP4APPMAOBCYP3A4 | |
| Ethyl Caffeate SCHEMBL27648151 | 0.95 | TTR (0.91) | TTRDPP4APPMAOBCYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 398 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250212873-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-07-03 | — | — | US | claimed |
| CN-120022380-A | Biotin-streptavidin mediated stem cell nano drug-loading system and preparation and application thereof | 洛兮医疗科技(杭州)有限公司 | 2025-05-23 | — | — | CN | claimed |
| EP-4482306-A1 | VOLATILE HDAC INHIBITORS FOR THERAPEUTIC AND PLANT APPLICATIONS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2025-01-01 | — | — | EP | claimed |
| CN-115209890-B | Shikonin, arylnaphthalene lignans and pharmaceutical compositions containing them for inhibiting expression of pro-inflammatory genes | 宝洁公司 | 2024-12-17 | — | — | CN | claimed |
| US-12163004-B2 | Polymer composites | WARNER BABCOCK INSTITUTE FOR GREEN CHEMISTRY, LLC (US) | 2024-12-10 | — | — | US | claimed |
| CN-118931618-A | Application of caffeic acid ethyl ester as antioxidant in preparation of synthetic ester insulating oil, antioxidant synthetic ester insulating oil and preparation method of antioxidant synthetic ester insulating oil | 广东电网有限责任公司 | 2024-11-12 | — | — | CN | claimed |
| WO-2024209462-A1 | ANTI-BIOFILM POLYMER COMPOSITIONS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2024-10-10 | — | — | WO | claimed |
| CN-118557563-A | Application of caffeic acid ethyl ester in preparation of medicines for treating pulmonary fibrosis and renal fibrosis | 华信青云科技有限公司 | 2024-08-30 | — | — | CN | claimed |
| CN-118440373-A | Method for preparing polyvinyl alcohol/caffeic acid phenethyl ester composite membrane in bionic lignification process | 中国林业科学研究院林产化学工业研究所 | 2024-08-06 | — | — | CN | claimed |
| EP-3705130-B1 | METHOD FOR SEPARATING EIGHT COMPONENTS IN CHINESE TRADITIONAL MEDICINE COMPOSITION | SHIJIAZHUANG YILING PHARMACEUTICAL CO LTD (CN) | 2024-07-17 | — | — | EP | claimed |
| US-20060172402-A1 | Production of vanillin in microbial cells | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY | 2006-08-03 | — | — | US | claimed |
| EP-1666051-A2 | Remedies | Takara Bio, Inc. (JP) | 2006-06-07 | — | — | EP | claimed |
| WO-2004036979-A2 | PRODUCTION OF VANILLIN IN MICROBIAL CELLS | RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY (US) | 2004-05-06 | — | — | WO | claimed |
| US-20040002423-A1 | Remedies | TAKARA BIO INC. (JP) | 2004-01-01 | — | — | US | claimed |
| US-20030203857-A1 | Polyphenols, derivatives, and/or salts as therapeutic or prophylactic agents, useful for treating a disease requiring enhancement for growth factor such as nerve growth factor and hepatocyte growth factor | TAKARA BIO INC. (JP) | 2003-10-30 | — | — | US | claimed |
| US-20030175777-A1 | Eleutherosides as adjuncts for vaccines and immune modulation | BONAGURA VINCENT R (US) | 2003-09-18 | — | — | US | claimed |
| WO-2003074000-A2 | ELEUTHEROSIDES AS ADJUNCTS FOR VACCINES AND IMMUNE MODULATION | OMEGA PHARMACEUTICAL, INC. (US) | 2003-09-12 | — | — | WO | claimed |
| CN-1422159-A | Therapeutic agents | TAKARA SHUZO CO (JP) | 2003-06-04 | — | — | CN | claimed |
| EP-1283037-A1 | REMEDIES | TAKARA BIO INC. (JP) | 2003-02-12 | — | — | EP | claimed |
| EP-1277473-A1 | REMEDIES | TAKARA BIO INC. (JP) | 2003-01-22 | — | — | EP | claimed |